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Abstract
The spread of SARS-COVID 19 infection has resulted in accelerated efforts at development and dissemination of
vaccines throughout the globe. These vaccines have different mechanisms of actions and their efﬁcacy and side effects
are being monitored. There have been rare reports in literature of thyroid dysfunction after COVID-19 vaccine
administration. Sub-acute thyroiditis is one such complication which can arise as a rare side-effect of vaccination. This
has also been reported as a symptom of COVID-19 infection. Clinical features include fever, neck pain, palpitations and
weight loss. We report sub-acute thyroiditis in a 50-year-old male who presented with symptoms suggestive of thyroid
abnormality one day after receiving the inactivated COVID-19 vaccine (CoronaVac Sinovac-Biotech Ltd).
Keywords: Subacute thyroiditis, COVID-19, Vaccine

1. Introduction

C

OVID-19 pandemic has been a major disruptive event of the 21st century having negative
implications for people's health and multiple facets
of everyday life. At the same time, it has been a
challenge for medical professionals to deal with the
unique manifestations of this novel disease. The
rapid development of vaccines has served to stem
the tide in the pandemic, and many different types
are being used throughout the globe with an
acceptable safety and efﬁcacy proﬁle. These include
inactivated virus (SInopharm, Sinovac), adenovirus
vectored (Oxford-Astrazeneca, Sputnik) and mRNA
vaccines (Pﬁzer-BioNTech, Moderna).1 The COVID19 vaccines have predominantly minor side effects
including fatigue, headache, fever and injection site
soreness.2 However, in rare instances major side
effects involving endocrine glands may occur with
thyrotoxicosis, thyroiditis and hypophysitis being
recently reported in literature as very rare side

effects.3,4 There is presence of adjuvants in the
vaccine which are used to increase the effectiveness
of the host's immune response.5 Sub-acute
thyroiditis is an inﬂammatory condition of the thyroid gland which is associated with local neck pain
and systemic symptoms, and is usually self-limited.
It has been reported as a side effect after administration of many viral vaccines which include H1N1,
inﬂuenza and hepatitis B vaccines.6e8 However,
there is a paucity of literature on post COVID-19
vaccination induced subacute thyroiditis, and there
are only a few reports documenting this phenomenon.9 We present a case of a 50-year-old male who
presented with features consistent with sub-acute
thyroiditis after receiving the inactivated COVID-19
vaccine (CoronaVac Sinovac-Biotech Ltd). The aim
of this article is to contribute to the existing literature regarding the safety proﬁle of the COVID-19
vaccines and awareness about rare side effects of
these vaccines.
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2. Case presentation
A 50-year-old man presented to the outpatient
department with complaints of fever, throat pain,
palpitations, and fatigue for the past 12 days. The
patient had received the second dose of the inactivated COVID-19 vaccine (CoronaVac SinovacBiotech Ltd). The fever was low grade and associated with anterior neck pain which was localized
over the right side of the thyroid gland and radiated
to the jaw. The patient also had a 2 kg weight loss in
these 12 days and had suffered from fatigue. About
four weeks prior to receiving the second vaccine
dose the patient received his ﬁrst dose and had
subsequently developed fever, throat discomfort
and fatigue within 12 h. These symptoms selfresolved after three days. On physical examination,
his temperature was 37.2  C, pulse was 92/min,
blood pressure was 135/80 mmHg and there was
tenderness over the thyroid gland. There was no
tremor or sweating.
His past medical history was signiﬁcant for
chronic Hepatitis B infection for the past 6 years for
which he was taking the anti-viral drug Tenofovir.
The patient was not suffering from an active upper
respiratory or COVID-19 infection which was
conﬁrmed by a negative COVID-19 PCR test. The
patient had no history of autoimmune or thyroid
disease and had never suffered from COVID-19
infection. Family history was signiﬁcant for hypertension in his mother. There was no family history
of autoimmune or thyroid disorders.
His lab investigations on the day of presentation
(Table 1) revealed abnormal thyroid function tests
with reduced TSH and slightly increased T3 levels.
The anti-thyroglobulin and anti-thyroid peroxidase
antibodies were also positive. He had an elevated
white cell count in addition to the deranged thyroid
function tests. BMP, lipid proﬁle and LFTs were
within normal range. The patient's TLC count was
raised. The thyroid ultrasound scan showed an
enlarged right lobe of the thyroid gland with multiple hypoechoic nodules and increased vascularity
Table 1. Laboratory investigations.
Parameter

Result Units

Reference values

Total T3
Free T4
TSH
Anti Thyroglobulin Abs
Anti-TPO (Th. microsomal)
TSH receptor Ab

0.5
1.1
0.01
11.2
10.1
0.80

ng/mL
ng/dL
uIU/mL
IU/mL
IU/mL
IU/L

CRP quantitative

0.04

mg/dL

WBC count

14210

/cmm

0.6e1.6
0.7e1.5
0.4e4.5
Negative: <4.1
Negative: <5.61
Negative: ¼ /<1.0
Equivocal: 1.1e1.5
Positive: >1.5
Negative: <0.5
Positive: >0.5
4-10k/cmm
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shown on color ﬂow. Technetium-99m thyroid scan
was then carried out which revealed an increase in
the size of the thyroid gland with reduced and
patchy tracer uptake and these ﬁndings reﬂected
subacute thyroiditis (Fig. 1).
The patient was prescribed propranolol to control
palpitations and paracetamol for neck pain and
fever. The patient's symptoms improved over the
next few weeks and there was no further weight
loss. After four weeks his thyroid function tests
revealed persistently decreased TSH but normal
levels of free T4 and T3.

3. Discussion
COVID 19 pandemic has increased strain on
healthcare setups throughout the world. However,
efforts directed by scientiﬁc community have yielded various vaccines which are being administered
globally. The vaccines have been instrumental in
reducing deaths and hospitalizations.10 Different
types include mRNA, adenovirus vector and inactivated whole virus vaccines.11 Inactivated vaccines
like CoronaVac (manufactured by Sinovac Biotech
Ltd) and BBIBP-CorV (made by Sinopharm) have
been the mainstay of vaccination effort in low to
middle income countries.12 Mild to moderate
adverse effects reported with these vaccines which
predominantly include local injection site pain,
fever, headache, fatigue and mucocutaneous eruption13 According to a study, at least 74% of the
people experienced one minor side-effect post
vaccination.14 Local side-effects were the most
common according to another study, with systemic
side-effects more prevalent in people who had suffered from COVID-19 infection previously.15
Subacute thyroiditis is known as the most common cause of painful thyroiditis. The exact etiology
is ambiguous but is thought to be most likely due to
viral infection. The clinical features include severe
pain (which may radiate to the jaw) and swelling
over the anterior neck, thyroid gland tenderness,
fever, malaise, palpitations and weight loss. Laboratory investigations show decreased TSH, elevated
ESR, CRP and thyroglobulin levels. Imaging modalities include thyroid ultrasound and radioiodine
uptake which show hypoechoic or anechoic lesions
and low thyroid uptake of radioiodine respectively.
Technetium-99 nuclear scans may show reduced
tracer uptake. Initial thyrotoxic clinical picture may
be followed by hypothyroid symptoms due to
depletion of thyroid stores.16 The condition however
is self-limiting with majority of patients returning to
euthyroid state within 6e12 months. Treatment of
the condition is mainly supportive, aimed at
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Fig. 1. Technetium-99m scan showing reduced tracer uptake in the thyroid gland.

reducing pain and preventing symptoms of hyper/
hypothyroidism. NSAIDS or salicylates are used to
relieve pain. Severe forms of the disease may warrant corticosteroid therapy.17
Subacute thyroiditis has been reported as a rare
manifestation of COVID-19 infection.18 There have
also been cases of thyroid dysfunction post COVID19 vaccination. Development of subacute thyroiditis
was reported in three female patients who had undergone vaccination from the inactivated CoronaVac
vaccine.19 There is also a case of a female patient
developing subacute thyroiditis after getting an
mRNA vaccine for COVID-19 (Pﬁzer/BioNTech),20
and another case of a female patient developing
subacute thyroiditis after vaccination from the
adenovirus-vectored COVID-19 vaccine (OxfordAstraZeneca). Anti-thyroid antibodies have been
positive in just one case of post COVID vaccination
sub-acute thyroiditis reported prior to our case, with
the anti-thyroglobulin antibody being positive in the
patient who had received the adenovirus-vectored
(Oxford-AstraZeneca) vaccine.21
The pathophysiology of thyroid abnormalities
after COVID-19 vaccination is unclear. It is believed

to be a result of autoimmune and inﬂammatory reaction to the adjuvants used in the vaccine.22 The
adjuvants used include aluminum hydroxide and
viral antigens, and serve to boost immune response
to the vaccine. But they can play a role in precipitating ASIA syndrome (autoimmune/inﬂammatory
syndrome induced by adjuvants). This may result
from disturbance of the host's immune system
equilibrium and molecular mimicry. The adjuvants
are used to improve the immunogenicity of the
vaccines, but they can lead to antibody production
and inﬂammation. The reaction of the body to adjuvants leads to B-cell activation, changes in the host
environment and rapid progression of molecular
mimicry. The systemic inﬂammatory condition
induced in the body as a result has rarely led to
endocrine gland dysfunction in the form of
thyroiditis, autoimmune diabetes, adrenal and
ovarian insufﬁciency.23 As per available literature, a
majority of the cases of sub-acute thyroiditis after
COVID-19 vaccination had onset of symptoms
within a few days of the administration of vaccine.
This can be due to the fact that viral proteins reach
their maximum level a few days after inoculation

and induce an autoimmune response.24 Our patient
had onset of symptoms 1 day after administration of
the second dose of the vaccine and didn't suffer
from any acute upper respiratory viral ailment or
COVID-19 in the days preceding the onset of
symptoms. No other case of thyroiditis post-vaccination by any type of COVID-19 vaccine has been
reported in literature in Pakistan since the launch of
the vaccination drive in February 2021. Sub-acute
thyroiditis after COVID-19 vaccination remains a
rare side effect which merits further investigation to
explore interplay of multiple factors involved in
manifestation of this clinical entity.
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BG, Şendur SN, Ünlütürk U. Three cases of subacute
thyroiditis following SARSCoV-2 vaccine: post-vaccination
ASIA syndrome, 27:dgab373 J Clin Endocrinol Metab. 2021;(9).
https://doi.org/10.1210/clinem/dgab373. Epub ahead of print.
PMID: 34043800; PMCID: PMC8194612.
10. Lopez Bernal J, Andrews N, Gower C, et al. Effectiveness of
the Pﬁzer-BioNTech and Oxford-AstraZeneca vaccines on

17.

18.

19.

20.

21.

22.

23.

24.

17

covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control
study. BMJ. 2021;373:n1088. https://doi.org/10.1136/bmj.n1088.
PMID: 33985964; PMCID: PMC8116636.
2006e. COVID-19 vaccines. Drugs and lactation database
(LactMed) [internet]. Bethesda (MD): National Library of
Medicine (US); 2021. PMID: 33355732.
Choi EM. COVID-19 vaccines for low- and middle-income
countries. Trans R Soc Trop Med Hyg. 2021;115(5):447e456.
https://doi.org/10.1093/trstmh/trab045.
Wu Z, Hu Y, Xu M, et al. Safety, tolerability, and immunogenicity of an inactivated SARSCoV-2 vaccine (CoronaVac) in
healthy adults aged 60 years and older: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial. Lancet
Infect Dis. 2021;21(6):803e812. https://doi.org/10.1016/S14733099(20)30987-7. Epub 2021 Feb 3. PMID: 33548194; PMCID:
PMC7906628.
Tissot N, Brunel AS, Bozon F, Rosolen B, Chirouze C,
Bouiller K. Patients with history of covid-19 had more side
effects after the ﬁrst dose of covid-19 vaccine. Vaccine. 2021;
39(36):5087e5090.
https://doi.org/10.1016/j.vaccine.2021.07.047. Epub 2021 Jul 22. PMID: 34332800; PMCID:
PMC8295016.
Menni Cristina, Klaser Kerstin, Anna May, et al. Vaccine sideeffects and SARS-CoV-2 infection after vaccination in users of
the COVID Symptom Study app in the UK: a prospective
observational study. Lancet Infect Dis. 2021;21:939e949.
San Juan MDJ, Florencio MQV, Joven MH. Subacute
thyroiditis in a patient with coronavirus disease 2019.
AACE Clin Case Rep. 2020;6(6):e361ee364. https://doi.org/
10.4158/ACCR-2020-0524. PMID: 33244504; PMCID: PMC
7685420.
Fatourechi Vahab, Aniszewski Jaroslaw P, Guiti Z,
Fatourechi Eghbali, Atkinson Elizabeth J, Jacobsen Steven J.
Clinical features and outcome of subacute thyroiditis in an
incidence cohort: olmsted county, Minnesota, study. J Clin
Endocrinol Metab. 2003;88(Issue 5):2100e2105.
Chakraborty U, Ghosh S, Chandra A, et al. Subacute
thyroiditis as a presenting manifestation of COVID-19: a
report of an exceedingly rare clinical entity. BMJ Case Rep.
2020;13, e239953. CP.
_
Iremli
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